J.P. Morgan Private Capital has closed an inaugural life sciences fund of more than $500 million, cash that will go toward a wide range of private biotechs and build value for existing portfolio ...

NEW YORK, July 11, 2024 /PRNewswire/ -- J.P. Morgan Private Capital, a venture and growth equity investment team within J.P. Morgan Asset Management Alternatives, today announced its next phase of ...

In a recently published report, J Capital Research says CCC Intelligent Solutions (CCCS) is “a low-growth software business from which executives ...

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Super X AI Technology Limited (“SuperX”) plunged 27% on Friday, September 5, 2025, after J Capital Research published a report alleging that the company is ...

Founded in 1991, J. Tucker is led by Jason and Tammy Tucker National partnered with Blue Point in December 2021 Blue Point Capital Partners invests in the lower mid-market National OnDemand, a ...

AMI is anticipated to become part of the Huber Specialty Minerals, a business unit within HEM Piper Sandler & Co. served as financial advisor to Golden Gate Capital and AMI on the deal Based in San ...

BMO Capital raised its price target on Protagonist Therapeutics to $112 from $72 and maintained an 'Outperform' rating, citing reports that Johnson & Johnson may acquire the biotech firm. In a note to ...

Season 2 of the MedCity Pivot Podcast has launched with a special focus on the evolution of phamacy and pharmacy benefit management. The first guest this season is A.J. Loiacono, who leads Capital Rx, ...

Tata Capital IPO price band is set between ₹310 and ₹326, open from October 6 to 8. It reserves shares for QIBs, NIIs, and ...

SAN JUAN, PUERTO RICO, January 6, 2025 /EINPresswire.com/ -- After two transformative years as a founding board member, Michael will now partner formally with ...